Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1: Animal preparation; a modified Glenn shunt was created between the SVC and the main pulmonary artery. A left ventricular assist device was implanted.

Published byNorah Crawford Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 1: Animal preparation; a modified Glenn shunt was created between the SVC and the main pulmonary artery. A left ventricular assist device was implanted."— Presentation transcript:

1 Figure 1: Animal preparation; a modified Glenn shunt was created between the SVC and the main pulmonary artery. A left ventricular assist device was implanted. Pressure volume loops were obtained throughout the experimental model in pigs ( n = 8). From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3): doi: /ejcts/ezv171 Eur J Cardiothorac Surg | © The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

2 Figure 2: Right atrial (RA) pressure (mmHg), during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3): doi: /ejcts/ezv171 Eur J Cardiothorac Surg | © The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

3 Figure 3: Right ventricular end-diastolic volume (RVEDV) (ml), during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3): doi: /ejcts/ezv171 Eur J Cardiothorac Surg | © The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

4 Figure 4: Right ventricular stroke volume (RVSV) (ml) during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3): doi: /ejcts/ezv171 Eur J Cardiothorac Surg | © The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

5 Figure 5: Right ventricular stroke work (RVSW) (mmHg ml), during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3): doi: /ejcts/ezv171 Eur J Cardiothorac Surg | © The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

6 Figure 6: Right ventricular developed pressure (mmHg) during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3): doi: /ejcts/ezv171 Eur J Cardiothorac Surg | © The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

7 Figure 7: Pressure (mmHg) and volume (ml) loops derived from the right ventricle during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3): doi: /ejcts/ezv171 Eur J Cardiothorac Surg | © The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Download ppt "Figure 1: Animal preparation; a modified Glenn shunt was created between the SVC and the main pulmonary artery. A left ventricular assist device was implanted."

Similar presentations

Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment.

Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment.
Figure 1: A PRISMA schematic of search strategy

Figure 1: A PRISMA schematic of search strategy
Figure 2. CONSORT flow diagram.

Figure 2. CONSORT flow diagram.
Control of ventricular unloading using an electrocardiogram-synchronized Thoratec paracorporeal ventricular assist device  Raffael Amacher, MSc, Alberto.

Control of ventricular unloading using an electrocardiogram-synchronized Thoratec paracorporeal ventricular assist device  Raffael Amacher, MSc, Alberto.
Figure 1: Different aortic bioprostheses

Figure 1: Different aortic bioprostheses
Table 1 Cause of death for arrested organ donors

Table 1 Cause of death for arrested organ donors
Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.
Figure 1 Patients outside of target international normalized ratio range by time point and management strategy. All values are expressed as percentages.

Figure 1 Patients outside of target international normalized ratio range by time point and management strategy. All values are expressed as percentages.
Figure 1: Forest plots. M-H: Mantel-Haenszel test; CI: confidence interval; SD: standard deviation; IV: inverse variance. Suction on chest drains following.

Figure 1: Forest plots. M-H: Mantel-Haenszel test; CI: confidence interval; SD: standard deviation; IV: inverse variance. Suction on chest drains following.
Figure 2: The Medical Imaging Projection System projecting the real-time fluorescent image on the surface of the lung during surgery (left). The cut surface.

Figure 2: The Medical Imaging Projection System projecting the real-time fluorescent image on the surface of the lung during surgery (left). The cut surface.
Figure 1 Study flow chart.

Figure 1 Study flow chart.
Figure 6 Case 6: (A) MRA showed occlusion of the left internal carotid artery. (B) MRI 4 days before cell injection and (C) 7 days after cell injection.

Figure 6 Case 6: (A) MRA showed occlusion of the left internal carotid artery. (B) MRI 4 days before cell injection and (C) 7 days after cell injection.
Fig. 1 Clinical model of coronary collateral flow

Fig. 1 Clinical model of coronary collateral flow
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
Figure 2 The incidence of new onset AF, strokes, heart failure, and mortality according to the BMI (/100 000 person-years). (Left: BMI

Figure 2 The incidence of new onset AF, strokes, heart failure, and mortality according to the BMI (/ person-years). (Left: BMI
Figure 4 Comparison of school and leisure time activity energy expenditure on weekdays between preschool and adolescent boys in different age categories.

Figure 4 Comparison of school and leisure time activity energy expenditure on weekdays between preschool and adolescent boys in different age categories.
Figure 1 Representative transoesophageal echocardiographic images of ventricular fibrillation during cardiopulmonary bypass. (A) Mid-oesophageal aortic.

Figure 1 Representative transoesophageal echocardiographic images of ventricular fibrillation during cardiopulmonary bypass. (A) Mid-oesophageal aortic.
Figure 1: Correlation of plasma ET-1 levels with LAD in patients with mitral valve disease. r is Pearson’s correlation coefficient. ET-1: endothelin 1;

Figure 1: Correlation of plasma ET-1 levels with LAD in patients with mitral valve disease. r is Pearson’s correlation coefficient. ET-1: endothelin 1;
From: Where do we go from here

From: Where do we go from here
Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Similar presentations

Ads by Google